Methyl Aminolevulinate
Back to searchMolecule Structure
Scientific Name
Methyl Aminolevulinate
Description of the Drug
Methyl aminolevulinate is a porphyrin precursor used to treat non-hyperkeratotic, non-pigmented actinic keratosis of the face and scalp.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00992
http://www.drugbank.ca/drugs/DB00992
Brand Name(s)
Metvix
Company Owner(s)
Galderma Laboratories Lp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL8521 | ||
PharmGKB | PA164784028 | ||
Human Metabolome Database | HMDB0015127 | ||
DrugBank | DB00992 | ||
PubChem: Thomson Pharma | 14747821 | ||
PubChem | 157922 | ||
Mcule | MCULE-8571939531 | ||
Nikkaji | J313.797J | ||
EPA CompTox Dashboard | DTXSID3048570 | ||
DrugCentral | 168 | ||
Brenda | 110301 | ||
rxnorm | METHYL 5-AMINOLEVULINATE | METHYL AMINOLEVULINATE HYDROCHLORIDE | METVIXIA |
ChEBI | 724125 | ||
ZINC | ZINC000001909090 |